<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.8042.36810 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 3/1/2022 9:56:01 PM -->
      <!-- iXBRL Library version: 1.0.8042.36816 -->
      <!-- iXBRL Service Job ID: 49bdbf6c-5212-4918-b3ec-92fa1d25c581 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:agti="http://www.agilitihealth.com/20220301" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityRegistrantName" id="Hidden_jED6efCC2ESjkTPE4uMr3w">AGILITI, INC. \DE</ix:nonNumeric><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityCentralIndexKey" id="Tc_6yy97Jebe0eHG8NSpkBNgQ_1_1">0001749704</ix:nonNumeric><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:AmendmentFlag" id="Tc_02ilUUq-zkal4Rn3n5GFbA_2_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="agti-20220301.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001749704</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><a id="_8c5e6b78_a34d_42fa_b6a6_8bc6ec736c8e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:DocumentType" id="Narr_Qib2Zeq6bkycCOldaiV9gg"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-size:12pt;font-weight:bold;">of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_1JSGDN_wGUGaN-n254F3kA"><b style="font-weight:bold;">March&#160;1, 2022</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_jED6efCC2ESjkTPE4uMr3w;"><b style="font-family:'Times New Roman','Times','serif';font-size:18pt;font-style:normal;font-weight:bold;">AGILITI,&#160;INC.</b></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Exact name of Registrant as specified in its charter)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_600834be_8f14_45fa_97ac_a21c4bb7581e"></a><a id="_f2ef04f4_1f76_4c8a_8d6a_f7873a4a6ca3"></a><a id="_a00d6425_6711_41ff_abaa_3a47254f8a9d"></a><a id="_f78fe09d_3259_4206_ae5a_37133cb7c57a"></a><a id="_64d5cd23_a480_42a4_99bd_8f7a73117f8b"></a><a id="Tc_6Mz6cQFLakSBQnJBIEsnAw_1_0"></a><a id="Tc_WkhnuOoF3EWgiZgWhq4RIQ_1_2"></a><a id="Tc_0rFa1NevOk2pStjOB0ywIA_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:31.83%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_9DWzobtYVUWxNwqKCbdqPg_0_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.24%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:31.83%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityFileNumber" id="Tc_M_CsrGDgXkKl4AhcnPROSw_0_2"><b style="font-weight:bold;">001-40361</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.24%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:31.83%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityTaxIdentificationNumber" id="Tc_4tSND84xikOdc4J0tUSV_g_0_4"><b style="font-weight:bold;">83-1608463</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:31.83%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(State or other jurisdiction</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">of incorporation)</b></p></td><td style="vertical-align:bottom;width:2.24%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:31.83%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Commission</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">File Number)</b></p></td><td style="vertical-align:bottom;width:2.24%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:31.83%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(I.R.S. Employer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><b style="font-weight:bold;">Identification No.)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityAddressAddressLine1" id="Narr_4hX-MuezDES-oSn57dxO2g"><b style="font-weight:bold;">6625 West 78th Street</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityAddressAddressLine2" id="Narr_Y1FkGkX6C0y1fkCESWfwGw"><b style="font-weight:bold;">Suite&#160;300</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityAddressCityOrTown" id="Narr_xFElysT5REaZYOJwd9bUrA"><b style="font-weight:bold;">Minneapolis</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityAddressStateOrProvince" id="Narr_mWaZXmsyJk67PSDDZaACrA"><b style="font-weight:bold;">MN</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:EntityAddressPostalZipCode" id="Narr_gDhUaaK600SWvEHy2S8A7g"><b style="font-weight:bold;">55439</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">(Address of </b><b style="font-weight:bold;">principal executive offices, including zip code</b><b style="font-weight:bold;">)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:CityAreaCode" id="Narr_RkzHVNvMEkSSGjGmJH_6zg"><b style="font-weight:bold;">952</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:LocalPhoneNumber" id="Narr_D6dqfFKnXE225tPXGbc6Fg"><b style="font-weight:bold;">893-3200</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">(</b><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code</b><b style="font-weight:bold;">)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_aqtSgdtQn0uqE6t7Z5GQBA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_ph6rOAejFk6mLeU1R24RRA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_t3Pv9MUIVU-C-EGxIChZtA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_uMgfJxe3KUauUdDup_W0MQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p><a id="_acff4a6c_0748_4936_8411_211abe6c5e9e"></a><a id="_f6b89163_1c48_4355_998d_e74a2ba205e4"></a><a id="Tc_DS75QRfgnESOaH9xeOhFBw_0_0"></a><a id="Tc_umHA4hYMdkCbuNIU3SP61Q_0_1"></a><a id="Tc_0ikPwB77jkOH8BZ9p1seWA_0_2"></a><a id="_bcac4ef8_3fc3_4b7d_bc7e_8b6b45244a27"></a><a id="_936de8ce_37c0_4ce1_aef4_2f240e00bafc"></a><a id="_b0bb9557_719f_4599_b72f_59a7063360aa"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:83.94%;"><tr><td style="vertical-align:top;width:33.32%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.25pt 0pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Title of each class</p></td><td style="vertical-align:top;width:33.99%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.25pt 0pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Trading Symbol</p></td><td style="vertical-align:top;width:32.68%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.25pt 0pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Name of each exchange on which registered</p></td></tr><tr><td style="vertical-align:top;width:33.32%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.25pt 0pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:Security12bTitle" id="Tc_xx1zmSc7602SWD7jQ6f9yg_1_0">Common Stock, par value $0.0001</ix:nonNumeric></p></td><td style="vertical-align:top;width:33.99%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.25pt 0pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" name="dei:TradingSymbol" id="Tc_DgZTVjFjsUqdP1WC_-lCmg_1_1">AGTI</ix:nonNumeric></p></td><td style="vertical-align:top;width:32.68%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 0.25pt 0pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_sgDDF5btN0Gq23uC3xYi6w_1_2">The New York Stock Exchange</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_3_1_2022_To_3_1_2022_iWcj7g-fhUG_qhOOA-ffLg" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_9AQd6Xi0VEucSR68kZKDiA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_38da6a8e_eb5c_4d50_a336_daf8e2abc969"></a><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="color:#a0a0a0;height:3.75pt;position:relative;top:0.6em;width:83.98%;margin:0 auto;"><a id="_dccec040_1025_4fec_b11f_0c081f2984ec"></a></div></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:84.76%;"><tr style="height:6pt;"><td style="vertical-align:middle;width:97.63%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Item 7.01 Regulation FD Disclosure.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On February 28, 2022, Agiliti, Inc. (the &#8220;Company&#8221;) entered into a new 12-month sole source agreement (the &#8220;Agreement&#8221;) with the U.S. Department of Health and Human Services&#8217; (&#8220;HHS&#8221;) Office of Assistant Secretary for Preparedness and Response (&#8220;ASPR&#8221;) to provide comprehensive ventilator and powered air purifying respirator (&#8220;PAPR&#8221;) systems management and maintenance services. This Agreement replaces the Company&#8217;s prior agreements with HHS/ASPR that ran from July 21, 2020, to February 27, 2022, and is comprised of an initial 6-month base term, running from the period of February 28, 2022, to August 27, 2022, and a 6-month option term that will expire February 27, 2023. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The term of this new Agreement will allow adequate time for HHS/ASPR to compete a longer-term agreement for comprehensive ventilator and PAPR systems management and maintenance services without having a lapse in critical COVID-19 pandemic response needs. HHS/ASPR solicited, negotiated and awarded the Agreement to the Company pursuant to Federal Acquisition Regulation (&#8220;FAR&#8221;) 6.302-2 Unusual and Compelling Urgency. Due to the unusual and compelling urgency of this requirement, HHS/ASPR determined that the Company is the only vendor that can provide comprehensive ventilator and PAPR management and maintenance as interim services on an expedited basis. Services include immediately providing all capabilities, such as, but not limited to, expertise, record management, labor, material, equipment, properly licensed and secure facilities to meet all of the current federal, state and local regulatory compliance, meeting stringent security, temperature control to maintain medical equipment, maintenance and repair services for the Division of Strategic National Stockpile (&#8220;DSNS&#8221;) cache of 167,574 ventilators, ventilator kits and supplies in 36,110 pallet positions and 164,950 PAPRs in 2,504 pallet positions. &#160;HHS/ASPR concluded that a lapse in service would cause irreparable harm to the government and therefore that the Agreement is necessary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The term of the Agreement will allow for transition to the competitive contract when awarded. Agiliti fully intends to compete for such future contract award. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Note Regarding Forward Looking Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Current Report on Form 8-K, including statements regarding the expected timing for HHS/ASPR&#8217;s public request for proposal and new contract award, are forward-looking statements. These forward-looking statements are subject to a number of factors and uncertainties that could cause our actual results to differ materially from those expressed in or contemplated by the forward-looking statements, including uncertainties with respect to timing of HHS/ASPR&#8217;s public request for proposal or award of a new contract; risks related to our ability to successfully compete for continuing contracts with HHS/ASPR following the expiration of the Agreement; and risks related to further renewal or termination of the Agreement or any of our existing contacts with HHS and ASPR. Other important risk factors are discussed in detail in the company&#8217;s filings with the Securities and Exchange Commission, including but not limited to, our Prospectus dated April 22, 2021 filed in connection with our initial public offering, our Quarterly Reports on Form 10-Q and any subsequent reports filed with the Securities and Exchange Commission. The&#160;forward-looking&#160;statements included in this Current Report on Form 8-K are made only as of the date hereof. We undertake no obligation to update or revise any&#160;forward-looking&#160;statement as a result of new information, future events or otherwise, except as otherwise required by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p></td><td style="vertical-align:middle;width:2.36%;margin:0pt;padding:0.25pt;"></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="color:#a0a0a0;height:3.75pt;position:relative;top:0.6em;width:83.98%;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_8234b4d1_8642_4335_a2c4_3ff3f5a67cb0"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">SIGNATURE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dated: March 1, 2022</p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">AGILITI, INC.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:44.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:44.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:44.35%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ James B. Pekarek</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:44.35%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">James B. Pekarek</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:44.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Executive Vice President and Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:4.47%;margin-right:4.47%;margin-top:30pt;page-break-after:avoid;width:91.06%;border:0;"></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "agti-20220301x8k.htm", "description": "8-K", "secsgml_size_bytes": 30948}]
{"company-data": {"conformed-name": "AGILITI, INC. \\DE", "cik": "0001749704", "assigned-sic": "7350", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-40361", "film-number": "22699555"}, "business-address": {"street1": "6625 WEST 78TH STREET, SUITE 300", "city": "MINNEAPOLIS", "state": "MN", "zip": "55439", "phone": "617-227-1050"}, "mail-address": {"street1": "6625 WEST 78TH STREET, SUITE 300", "city": "MINNEAPOLIS", "state": "MN", "zip": "55439"}}
​
​
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 1, 2022
AGILITI, INC.
(Exact name of Registrant as specified in its charter)
​
Delaware
001-40361
83-1608463
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
​
6625 West 78th Street
,
Suite 300
Minneapolis
,
MN
55439
(Address of
principal executive offices, including zip code
)
(
952
)
893-3200
(
Registrant's telephone number, including area code
)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, par value $0.0001
AGTI
The New York Stock Exchange
​
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
​
​
​
Item 7.01 Regulation FD Disclosure.
​
On February 28, 2022, Agiliti, Inc. (the "Company") entered into a new 12-month sole source agreement (the "Agreement") with the U.S. Department of Health and Human Services' ("HHS") Office of Assistant Secretary for Preparedness and Response ("ASPR") to provide comprehensive ventilator and powered air purifying respirator ("PAPR") systems management and maintenance services. This Agreement replaces the Company's prior agreements with HHS/ASPR that ran from July 21, 2020, to February 27, 2022, and is comprised of an initial 6-month base term, running from the period of February 28, 2022, to August 27, 2022, and a 6-month option term that will expire February 27, 2023.
​
The term of this new Agreement will allow adequate time for HHS/ASPR to compete a longer-term agreement for comprehensive ventilator and PAPR systems management and maintenance services without having a lapse in critical COVID-19 pandemic response needs. HHS/ASPR solicited, negotiated and awarded the Agreement to the Company pursuant to Federal Acquisition Regulation ("FAR") 6.302-2 Unusual and Compelling Urgency. Due to the unusual and compelling urgency of this requirement, HHS/ASPR determined that the Company is the only vendor that can provide comprehensive ventilator and PAPR management and maintenance as interim services on an expedited basis. Services include immediately providing all capabilities, such as, but not limited to, expertise, record management, labor, material, equipment, properly licensed and secure facilities to meet all of the current federal, state and local regulatory compliance, meeting stringent security, temperature control to maintain medical equipment, maintenance and repair services for the Division of Strategic National Stockpile ("DSNS") cache of 167,574 ventilators, ventilator kits and supplies in 36,110 pallet positions and 164,950 PAPRs in 2,504 pallet positions.  HHS/ASPR concluded that a lapse in service would cause irreparable harm to the government and therefore that the Agreement is necessary.
​
The term of the Agreement will allow for transition to the competitive contract when awarded. Agiliti fully intends to compete for such future contract award.
​
Note Regarding Forward Looking Statements
​
This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Current Report on Form 8-K, including statements regarding the expected timing for HHS/ASPR's public request for proposal and new contract award, are forward-looking statements. These forward-looking statements are subject to a number of factors and uncertainties that could cause our actual results to differ materially from those expressed in or contemplated by the forward-looking statements, including uncertainties with respect to timing of HHS/ASPR's public request for proposal or award of a new contract; risks related to our ability to successfully compete for continuing contracts with HHS/ASPR following the expiration of the Agreement; and risks related to further renewal or termination of the Agreement or any of our existing contacts with HHS and ASPR. Other important risk factors are discussed in detail in the company's filings with the Securities and Exchange Commission, including but not limited to, our Prospectus dated April 22, 2021 filed in connection with our initial public offering, our Quarterly Reports on Form 10-Q and any subsequent reports filed with the Securities and Exchange Commission. The forward-looking statements included in this Current Report on Form 8-K are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.
​
​
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
​
Dated: March 1, 2022
AGILITI, INC.
​
​
​
​
​
​
​
By:
/s/ James B. Pekarek
​
Name:
James B. Pekarek
​
Title:
Executive Vice President and Chief Financial Officer
​
​
​